FDA approves carfilzomib and daratumumab with dexamethasone for multiple myeloma
On August 20, 2020, the Food and Drug Administration approved carfilzomib and daratumumab in combination…
Browsing: dexamethasone
Protected: Novel triplet therapy for newly diagnosed multiple myeloma patients now PBS listed
This content is password protected. To view it please enter your password below: Password:
FDA approves new therapy for patients with previously treated multiple myeloma
Today, the U.S. Food and Drug Administration (FDA) approved isatuximab-irfc, in combination with pomalidomide and…
ASH 2019: Triple drug combination delays disease progression in people with stubborn multiple myeloma
Adding daratumumab to carfilzomib and dexamethasone to treat patients with relapsed or refractory multiple myeloma…
Protected: Novel triplet therapy for newly diagnosed multiple myeloma patients now TGA approved
This content is password protected. To view it please enter your password below: Password:
Protected: New triplet therapy for patients with multiple myeloma now TGA approved
This content is password protected. To view it please enter your password below: Password:
EHA 2019: Venetoclax with bortezomib and dexamethasone shows good response but higher risk of treatment related death in relapsed / refractory multiple myleoma
Multiple myeloma is the second most common haematological cancer, and despite significant progress in the…